PDL Biopharma OverviewPDL Biopharma Research & Development
Research & Development expenses for PDLI.
Quarterly R&D Expenses
N/A
As of Sep 30, 2020
Annual R&D Expenses (TTM)
$4.56M
↓ 33.58% YoY
Trailing 12 months ending Sep 30, 2020
PDL Biopharma OverviewResearch & Development expenses for PDLI.
As of Sep 30, 2020
Trailing 12 months ending Sep 30, 2020